CLARITY (Clinical Assessment of Response in the Treatment of Depression with Daytime Sleepiness Using Solriamfetol) is a Phase 3, double-blind, placebo-controlled, multicenter randomized withdrawal ...
A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of Medicine at Mount Sinai has found that the serum of patients with major ...
Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...
Major depressive disorder is linked to Th2 immune dysregulation similar to atopic dermatitis. Could dupilumab offer a new ...
Major depressive disorder is another name for depression. It can cause a persistent low mood, sleep disturbances, difficulty focusing, a loss of motivation, and other symptoms. A person with major ...
Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, ...
8don MSN
Single dose of a psychedelic drug can rapidly reduce depressive symptoms, clinical trial suggests
A single dose of the psychedelic drug dimethyltryptamine (DMT), given with psychological support, rapidly reduced depressive ...
HELUS Pharma has rebranded and moved to Nasdaq, signaling a shift toward late-stage clinical development and commercial focus ...
"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results